UC Davis Center for Accelerated Innovation
UC Davis was recently funded as part of the consortium of the five University of California campuses at Davis, Irvine, Los Angeles, San Diego and San Francisco. The UC Center for Accelerated Innovation (UC CAI) was designated as one of three Centers for Accelerated Innovations by the National Heart, Lung and Blood Institute (NHLBI). The award, among the first of its kind from NHLBI, recognizes the University of California’s potential to translate its leading-edge discoveries into innovative products that benefit patients.
The University of California Center for Accelerated Innovation (UC CAI) will leverage the expertise and resources of the five state medical campuses and use industrial product-development practices to incubate technologies with high commercial potential.
Learn more about . . .
The UC CAI invites applications for development of novel technologies that address heart, lung and blood diseases. This opportunity will support a broad range of drugs, devices (including wireless devices) and diagnostics with high potential of becoming clinically useful and commercially viable products.
Nov 18, 2013 - RFA release
Nov 21, 2013 - Webinar then click on the "webinar" tab
Dec 2, 2013 - Submission of pre-applications begins
Dec 20, 2013 - Pre-application closes @ 5 PM PT
Feb 3, 2014 - Pre-application notification
Apr 3, 2014 - Full application notification
Jun 3, 2014 - Earliest start date